SAN DIEGO--(BUSINESS WIRE)--May 13, 2019--
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery
and diabetes technology company, today announced that management will
present a Company update at the following upcoming investor conferences:
- Bank of America Merrill Lynch Healthcare Conference on Wednesday, May
15, 2019 in Las Vegas at 7:20pm Eastern Time (4:20pm Pacific Time).
- UBS Global Healthcare Conference on Monday, May 20, 2019 in New York
City at 3:30pm Eastern Time (12:30pm Pacific Time).
The presentations will be webcast live, and an archive recording will be
available for 30 days. The link to the live webcast and archive will be
accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com
in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company dedicated to improving the lives of people
with diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach to
the design, development and commercialization of products for people
with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™
insulin pump, is capable of remote software updates using a personal
computer and features integrated continuous glucose monitoring. Tandem
is based in San Diego, California.
Tandem Diabetes Care is a registered trademark and t:slim X2 is a
trademark of Tandem Diabetes Care, Inc.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2,
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190513005642/en/
Source: Tandem Diabetes Care, Inc.